» Articles » PMID: 26943577

Diagnostic and Prognostic Relevance of Circulating Exosomal MiR-373, MiR-200a, MiR-200b and MiR-200c in Patients with Epithelial Ovarian Cancer

Overview
Journal Oncotarget
Specialty Oncology
Date 2016 Mar 5
PMID 26943577
Citations 139
Authors
Affiliations
Soon will be listed here.
Abstract

Exosomes are membrane vesicles that mediate intercellular communication by transporting their molecular cargo from cell to cell. We investigated whether serum levels of exosomal miR-373, miR-200a, miR-200b and miR-200c and circulating exosomes have diagnostic and prognostic relevance in a cohort of 163 epithelial ovarian cancer (EOC) patients using TaqMan MicroRNA assays and ELISA. The serum concentrations of exosomal miR-373 (p = 0.0001), miR-200a (p = 0.0001), miR-200b (p = 0.0001) and miR-200c (p = 0.028) were significantly higher in EOC patients than healthy women. The levels of miR-200a (p = 0.0001), miR-200b (p = 0.0001) and miR-200c (p = 0.019) could distinguish between malignant and benign ovarian tumors. While the levels of miR-373 and miR-200a were increased in all FIGO/lymph node stages (p = 0.0001), the levels of miR-200b and miR-200c were higher in patients with FIGO stage III-IV (p = 0.0001, p = 0.008, respectively) including lymph node metastasis (p = 0.0001, p = 0.004, respectively) than FIGO stages I-II. The increased levels of miR-200b and miR-200c were also associated with CA125 values (p = 0.0001, p = 0.0001, respectively) and a shorter overall survival (p = 0.007, p = 0.017, respectively). The levels of exosomes were excessively elevated in EOC patients (p = 0.0001). In all three cohorts, they were positively associated with the serum levels of exosomal miR-373 (p = 0.004), miR-200a (p = 0.0001), miR-200b (p = 0.0001) and miR-200c (p = 0.008). In conclusion, the increased levels of exosomal miR-200b and miR-200c mainly observed in advanced EOC suggest that these microRNAs may be involved in tumor progression. The high concentrations of exosomes in EOC patients imply an excessive, active exosomal secretion in EOC.

Citing Articles

Role of cell-free DNA and extracellular vesicles for diagnosis and surveillance in patients with glioma.

Karacam B, Elbasan E, Khan I, Akdur K, Mahfooz S, Cavusoglu M J Liq Biopsy. 2025; 4:100142.

PMID: 40027145 PMC: 11863929. DOI: 10.1016/j.jlb.2024.100142.


Advances in small extracellular vesicles: roles in the tumor microenvironment and epithelial ovarian cancer diagnosis and treatment.

Peng L, Lai Y, Cao B Front Oncol. 2025; 15:1526944.

PMID: 40008006 PMC: 11850269. DOI: 10.3389/fonc.2025.1526944.


Circulating microRNAs as Diagnostic Biomarkers to Detect Specific Stages of Ovarian Cancer: A Comprehensive Meta-Analysis.

Kartikasari A, Michel-Lara P, Exton H, Tekin-Sari K, Alnefai E, Mitchell A Cancers (Basel). 2025; 16(24.

PMID: 39766088 PMC: 11674734. DOI: 10.3390/cancers16244190.


Value of miR200b and its combination with other biochemical markers in the diagnosis of epithelial ovarian cancer.

Helmy D, Mossallam G, Radwan N, Kamal A, Attia I Mol Biol Rep. 2024; 52(1):35.

PMID: 39638936 DOI: 10.1007/s11033-024-10103-9.


Blood mir-331-3p is a potential diagnostic marker for giant panda (Ailuropoda melanoleuca) testicular tumor.

Zhu Y, Huang Z, Li C, Li C, Wei M, Deng L BMC Vet Res. 2024; 20(1):515.

PMID: 39548579 PMC: 11566409. DOI: 10.1186/s12917-024-04326-y.


References
1.
Kobayashi M, Salomon C, Tapia J, Illanes S, Mitchell M, Rice G . Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200. J Transl Med. 2014; 12:4. PMC: 3896684. DOI: 10.1186/1479-5876-12-4. View

2.
Krol J, Loedige I, Filipowicz W . The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010; 11(9):597-610. DOI: 10.1038/nrg2843. View

3.
Humphries B, Yang C . The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy. Oncotarget. 2015; 6(9):6472-98. PMC: 4466628. DOI: 10.18632/oncotarget.3052. View

4.
Davidson B, Trope C, Reich R . Epithelial-mesenchymal transition in ovarian carcinoma. Front Oncol. 2012; 2:33. PMC: 3356037. DOI: 10.3389/fonc.2012.00033. View

5.
Calin G, Sevignani C, Dumitru C, Hyslop T, Noch E, Yendamuri S . Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004; 101(9):2999-3004. PMC: 365734. DOI: 10.1073/pnas.0307323101. View